Nowak; Ireneusz

Patent Applications and Registrations

Patent applications and USPTO patent grants for Nowak; Ireneusz.The latest application filed is for "immune regulatory oligonucleotide (iro) compounds to modulate toll-like receptor based immune response".

Company Profile

0.11.13

Nowak; Ireneusz - Allston MA
Nowak; Ireneusz - Cambridge MA
Nowak; Ireneusz - Provo UT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response Grant 10,066,230 - Kandimalla , et al. September 4, 2	2018-09-04
Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response Grant 10,041,076 - Kandimalla , et al. August 7, 2	2018-08-07
Immune Regulatory Oligonucleotide (iro) Compounds To Modulate Toll-like Receptor Based Immune Response App 20180023085 - Kandimalla; Ekambar R. ; et al.	2018-01-25
Immune Regulatory Oligonucleotide (iro) Compounds To Modulate Toll-like Receptor Based Immune Response App 20170233741 - Kandimalla; Ekambar R. ; et al.	2017-08-17
Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response Grant 9,540,651 - Kandimalla , et al. January 10, 2	2017-01-10
Immune Regulatory Oligonucleotide (iro) Compounds To Modulate Toll-like Receptor Based Immune Response App 20160312225 - Kandimalla; Ekambar R. ; et al.	2016-10-27
Immune Regulatory Oligonucleotide (iro) Compounds To Modulate Toll-like Receptor Based Immune Response App 20160215287 - Kandimalla; Ekambar R. ; et al.	2016-07-28
Immune Regulatory Oligonucleotide (iro) Compounds To Modulate Toll-like Receptor Based Immune Response App 20160201060 - Kandimalla; Ekambar ; et al.	2016-07-14
Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response Grant 9,260,719 - Kandimalla , et al. February 16, 2	2016-02-16
Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response Grant 9,096,858 - Kandimalla , et al. August 4, 2	2015-08-04
Compositions for Inhibiting Gene Expression and Uses Thereof App 20150044196 - Agrawal; Sudhir ; et al.	2015-02-12
Compositions for inhibiting gene expression and uses thereof Grant 8,877,722 - Agrawal , et al. November 4, 2	2014-11-04
Immune Regulatory Oligonucleotide (iro) Compounds To Modulate Toll-like Receptor Based Immune Response App 20140193396 - Kandimalla; Ekambar R. ; et al.	2014-07-10
Immune Regulatory Oligonucleotide (iro) Compounds To Modulate Toll-like Receptor Based Immune Response App 20140004100 - Kandimalla; Ekambar R. ; et al.	2014-01-02
Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response Grant 8,486,908 - Kandimalla , et al. July 16, 2	2013-07-16
Compositions For Inhibiting Gene Expression And Uses Thereof App 20130142778 - AGRAWAL; SUDHIR ; et al.	2013-06-06
Immune Regulatory Oligonucleotide (iro) Compounds To Modulate Toll-like Receptor Based Immune Response App 20120128699 - Kandimalla; Ekambar R. ; et al.	2012-05-24
Perfluoropolyether primary bromides and lodides Grant 7,148,385 - Howell , et al. December 12, 2	2006-12-12
Perfluoropolyether primary bromides and lodides App 20040024250 - Howell, Jon L. ; et al.	2004-02-05
Perfluoropolyether primary bromides and iodides Grant 6,653,511 - Howell , et al. November 25, 2	2003-11-25
Perfluoropolyether primary bromides and iodides App 20030013924 - Howell, Jon L. ; et al.	2003-01-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.